These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28432514)

  • 41. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.
    Hartley MC; McKinley BP; Rogers EA; Kalbaugh CA; Messich HS; Blackhurst DW; Lokey JS; Trocha SD
    Am Surg; 2006 Dec; 72(12):1189-94; discussion 1194-5. PubMed ID: 17216817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
    Land LH; Dalton SO; Jensen MB; Ewertz M
    Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
    Moger TA; Bjørnelv GM; Aas E
    Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer.
    Zhang Y; Franzini L; Chan W; Xu H; Du XL
    J Health Care Poor Underserved; 2015 Nov; 26(4):1336-58. PubMed ID: 26548682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Financial Costs and Burden Related to Decisions for Breast Cancer Surgery.
    Greenup RA; Rushing C; Fish L; Campbell BM; Tolnitch L; Hyslop T; Peppercorn J; Wheeler SB; Zafar SY; Myers ER; Hwang ES
    J Oncol Pract; 2019 Aug; 15(8):e666-e676. PubMed ID: 31356147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women.
    Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
    Med Care; 2011 Jan; 49(1):89-95. PubMed ID: 21079524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims.
    Khemiri A; Kharitonova E; Zah V; Ruby J; Toumi M
    Postgrad Med; 2014 Sep; 126(5):113-20. PubMed ID: 25295655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
    Yoon TI; Hwang UK; Kim ET; Lee S; Sohn G; Ko BS; Lee JW; Son BH; Kim S; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):311-320. PubMed ID: 28601930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health State Utility Impact of Breast Cancer in U.S. Women Aged 18-44 Years.
    Brown DS; Trogdon JG; Ekwueme DU; Chamiec-Case L; Guy GP; Tangka FK; Li C; Trivers KF; Rodriguez JL
    Am J Prev Med; 2016 Feb; 50(2):255-61. PubMed ID: 26775904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absenteeism and short-term disability associated with breast cancer.
    Fu AZ; Chen L; Sullivan SD; Christiansen NP
    Breast Cancer Res Treat; 2011 Nov; 130(1):235-42. PubMed ID: 21567238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer.
    Sedjo RL; Devine S
    Breast Cancer Res Treat; 2011 Jan; 125(1):191-200. PubMed ID: 20495864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stage at diagnosis and comorbidity influence breast cancer survival in First Nations women in Ontario, Canada.
    Sheppard AJ; Chiarelli AM; Marrett LD; Nishri ED; Trudeau ME
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2160-7. PubMed ID: 21803843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
    Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
    J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
    Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
    Lerro CC; Robbins AS; Fedewa SA; Ward EM
    Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast cancer during pregnancy: maternal and fetal outcomes.
    Cardonick E; Dougherty R; Grana G; Gilmandyar D; Ghaffar S; Usmani A
    Cancer J; 2010; 16(1):76-82. PubMed ID: 20164696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.